Quarterly Updates30 May 2026, 07:52 pm
Aarey Drugs FY26: Revenue from Operations ₹47,394.33 Lakhs
AI Summary
Aarey Drugs & Pharmaceuticals Ltd's board approved the audited standalone financial results for the fourth quarter and year ended March 31, 2026. The company's Revenue from Operations stood at ₹47,394.33 Lakhs for the year ended March 31, 2026. The board meeting, which commenced at 5:00 P.M. and concluded at 7:20 P.M., also approved a statement of deviation or variation in utilization of funds raised through convertible warrants.
Key Highlights
- Aarey Drugs' board approved audited standalone financial results for FY26.
- Revenue from Operations for FY26 is ₹47,394.33 Lakhs.
- The board also approved a statement of deviation in fund utilization.
- Trading window will open 48 hours after the announcement of results.
- Basic EPS for the year ended March 31, 2026 is ₹1.39.
Price Impact
More from AREYDRG